financetom
Business
financetom
/
Business
/
Slower production growth will push copper market to deficit in 2026, says ICSG
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Slower production growth will push copper market to deficit in 2026, says ICSG
Oct 8, 2025 8:00 AM

LONDON (Reuters) -The global refined copper market is expected to swing to a deficit of 150,000 metric tons in 2026 from the previously expected surplus of 209,000 tons due to slower production growth, the International Copper Study Group (ICSG) said.

Copper prices briefly hit a 16-month peak on Wednesday due to worries about potential shortages from a series of recent mine disruptions in Indonesia, Chile and Congo.

These incidents prompted the ICSG to revise down its forecast for the 2025 global mine production growth to 1.4% from 2.3% it expected in April, it said in a statement on Wednesday.

For 2025, these incidents will narrow down the surplus in the refined copper market to 178,000 tons from the previously expected 289,000 tons.

In 2026, the industry body expects the mine output to rise by 2.3% due to the ramp-up of new or expanded capacity around the globe, improved output from Chile, Peru and Zambia as well as a recovery of mining in Indonesia.

The growth in the refined production is expected to slow down to 0.9% in 2026 from 3.4% in 2025, as constrained availability of copper concentrates will partially offset higher output from scrap.

The ICSG now expects the global refined copper usage to rise by 2.1% to 28.7 million tons in 2026, compared with 3% in 2025, as consumption growth in China will slow down.

China accounts for 58% of the global refined copper usage.

"Asia will continue to be the main driver of global growth, with demand in other key copper-using regions remaining subdued, notably in the European Union and Japan," the ICSG said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved